MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZ

Cell Death and Disease

Volumn 6, Issue 1, 2015, Pages

  Zuo, Q F ^a   Zhang, R ^b   Li, B S ^a   Zhao, Y L ^a   Zhuang, Y ^a   Yu, T ^a   Gong, L ^a   Li, S ^a   Xiao, B ^a   Zou, Q M ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; MICRORNA; MICRORNA 141; MICRORNA 24; MICRORNA 29C; MICRORNA LET 7A; PROTEIN; SURVIVIN; TAZ PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; MIRN141 MICRORNA, HUMAN; SIGNAL PEPTIDE; WWTR1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER SIZE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GASTRIC CANCER CELL LINE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MALE; METASTASIS; MOUSE; NONHUMAN; PDZ DOMAIN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR INVASION; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; SECONDARY; STOMACH TUMOR;

MUS; MUS MUSCULUS;

ADULT; AGED; ANIMALS; BASE SEQUENCE; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; STOMACH NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84927646701     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.573     Document Type: Article

References (45)

1. Danaei G, Vander HS, Lopez AD, Murray CJ, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005; 366: 1784-1793.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. J Surg Oncol 2013; 107: 230-236.
4. Jiang X, Tseng CC, Bernstein L, Wu AH. Family history of cancer and gastroesophageal disorders and risk of esophageal and gastric adenocarcinomas: a case-control study. BMC Cancer 2014; 14: 60.
5. Yaghoobi M, Bijarchi R, Narod SA. Family history and the risk of gastric cancer. Br J Cancer 2010; 102: 237-242.
6. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010; 19: 1893-1907.
7. Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol Hematol 2009; 71: 127-164.
8. Iorio MV, Croce CM. microRNA involvement in human cancer. Carcinogenesis 2012; 33: 1126-1133.
9. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
10. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10: 704-714.
11. Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J et al. MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 2010; 29: 5761-5771.
12. Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY, Yan M. microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep 2012; 27: 1019-1026.
13. Li X, Zhang Y, Zhang H, Liu X, Gong T, Li M et al. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 2011; 9: 824-833.
14. Han TS, Hur K, Xu G, Choi B, Okugawa Y, Toiyama Y et al. MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1. Gut 2015; 64: 203-214.
15. Li BS, Zuo QF, Zhao YL, Xiao B, Zhuang Y, Mao XH et al. MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival. Oncogene 2014 (in press).
16. Mateescu B, Batista L, Cardon M, Gruosso T, de Feraudy Y, Mariani O et al. miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med 2011; 17: 1627-1635.
17. van Jaarsveld MT, Helleman J, Boersma AW, van Kuijk PF, van Ijcken WF, Despierre E et al. miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells. Oncogene 2013; 32: 4284-4293.
18. Liu Y, Ding Y, Huang J, Wang S, Ni W, Guan J et al. MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1. PLoS One 2014; 9: e88393.
19. Chen X, Wang X, Ruan A, Han W, Zhao Y, Lu X et al. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression. Clin Cancer Res 2014; 20: 2617-2630.
20. Hur K, Toiyama Y, Takahashi M, Balaguer F, Nagasaka T, Koike J et al. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut 2013; 62: 1315-1326.
21. Xu L, Li Q, Xu D, Wang Q, An Y, Du Q et al. hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration. Int J Oncol 2014; 44: 459-466.
22. Chen B, Huang T, Jiang J, Lv L, Li H, Xia S. miR-141 suppresses proliferation and motility of gastric cancer cells by targeting HDGF. Mol Cell Biochem 2014; 388: 211-218.
23. Du Y, Xu Y, Ding L, Yao H, Yu H, Zhou T et al. Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J Gastroenterol 2009; 44: 556-561.
24. Zhou X, Xia Y, Su J, Zhang G. Down-regulation of miR-141 induced by Helicobacter pylori promotes the invasion of gastric cancer by targeting STAT4. Cell Physiol Biochem 2014; 33: 1003-1012.
25. Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, Donowitz M et al. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J 2000; 19: 6778-6791.
26. Pan D. The hippo signaling pathway in development and cancer. Dev Cell 2010; 19: 491-505.
27. Cui CB, Cooper LF, Yang X, Karsenty G, Aukhil I. Transcriptional coactivation of bonespecific transcription factor Cbfa1 by TAZ. Mol Cell Biol 2003; 23: 1004-1013.
28. Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R et al. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 2005; 309: 1074-1078.
29. Mahoney WJ, Hong JH, Yaffe MB, Farrance IK. The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem J 2005; 388: 217-225.
30. Murakami M, Nakagawa M, Olson EN, Nakagawa O. A. WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome. Proc Natl Acad Sci USA 2005; 102: 18034-18039.
31. Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 2011; 147: 759-772.
32. Bhat KP, Salazar KL, Balasubramaniyan V, Wani K, Heathcock L, Hollingsworth F et al. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev 2011; 25: 2594-2609.
33. Tseng CW, Lin CC, Chen CN, Huang HC, Juan HF. Integrative network analysis reveals active microRNAs and their functions in gastric cancer. BMC Syst Biol 2011; 5: 99.
34. Gomes LL, Moreira FC, Hamoy IG, Santos S, Assumpcao P, Santana AL et al. Identification of miRNAs expression profile in gastric cancer using self-organizing maps (SOM). Bioinformation 2014; 10: 246-250.
35. Zhang H, Liu CY, Zha ZY, Zhao B, Yao J, Zhao S et al. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J Biol Chem 2009; 284: 13355-13362.
36. Pobbati AV, Hong W. Emerging roles of TEAD transcription factors and its coactivators in cancers. Cancer Biol Ther 2013; 14: 390-398.
37. Tamagawa S, Beder LB, Hotomi M, Gunduz M, Yata K, Grenman R et al. Role of miR-200c/ miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma. Int J Mol Med 2014; 33: 879-886.
38. Xiong M, Jiang L, Zhou Y, Qiu W, Fang L, Tan R et al. The miR-200 family regulates TGFbeta1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J Physiol Renal Physiol 2012; 302: F369-F379.
39. Mei Z, He Y, Feng J, Shi J, Du Y, Qian L et al. MicroRNA-141 promotes the proliferation of non-small cell lung cancer cells by regulating expression of PHLPP1 and PHLPP2. FEBS Lett 2014; 588: 3055-3061.
40. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 2007; 17: 2054-2060.
41. Zhao B, Lei QY, Guan KL. The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol 2008; 20: 638-646.
42. Chan SW, Lim CJ, Guo K, Ng CP, Lee I, Hunziker W et al. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res 2008; 68: 2592-2598.
43. De Cristofaro T, Di Palma T, Ferraro A, Corrado A, Lucci V, Franco R et al. TAZ/WWTR1 is overexpressed in papillary thyroid carcinoma. Eur J Cancer 2011; 47: 926-933.
44. Zhou Z, Hao Y, Liu N, Raptis L, Tsao MS, Yang X. TAZ is a novel oncogene in non-small cell lung cancer. Oncogene 2011; 30: 2181-2186.
45. Sudol M. Newcomers to the WW domain-mediated network of the Hippo tumor suppressor pathway. Genes Cancer 2010; 1: 1115-1118.